SEC Form 4 · accession 0001209191-18-030237
CRISPR Therapeutics AG · CRSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ali Behbahani
Director
Period of report
May 14, 2018
Accepted (ET)
May 15, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2018 | J | 199 | $0.00 | A | 199 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1NEA Partners 15, L.P. ("NEA Partners 15") made a pro rata distribution for no consideration of an aggregate of 20,879 shares of Common Stock of the Issuer to its limited partners on May 14, 2018. The Reporting Person received 199 shares of Common Stock of the Issuer in the distribution by NEA Partners 15 on May 14, 2018.